Effect of Vitamin K2 on Postural Sway in Older People Who Fall: A Randomized Controlled Trial.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
10 2019
Historique:
received: 01 04 2019
revised: 12 05 2019
accepted: 19 05 2019
pubmed: 19 6 2019
medline: 19 5 2020
entrez: 19 6 2019
Statut: ppublish

Résumé

Vitamin K is thought to be involved in both bone health and maintenance of neuromuscular function. We tested the effect of vitamin K2 supplementation on postural sway, falls, healthcare costs, and indices of physical function in older people at risk of falls. Parallel-group double-blind randomized placebo-controlled trial. Fourteen primary care practices in Scotland, UK. A total of 95 community-dwelling participants aged 65 and older with at least two falls, or one injurious fall, in the previous year. Once/day placebo, 200 μg or 400 μg of oral vitamin K2 for 1 year. The primary outcome was anteroposterior sway measured using sway plates at 12 months, adjusted for baseline. Secondary outcomes included the Short Physical Performance Battery, Berg Balance Scale, Timed Up & Go Test, quality of life, health and social care costs, falls, and adverse events. Mean participant age was 75 (standard deviation [SD] = 7) years. Overall, 58 of 95 (61%) were female; 77 of 95 (81%) attended the 12-month visit. No significant effect of either vitamin K2 dose was seen on the primary outcome of anteroposterior sway (200 μg vs placebo: -.19 cm [95% confidence interval [CI] -.68 to .30; P = .44]; 400 μg vs placebo: .17 cm [95% CI -.33 to .66; P = .50]; or 400 μg vs 200 μg: .36 cm [95% CI -.11 to .83; P = .14]). Adjusted falls rates were similar in each group. No significant treatment effects were seen for other measures of sway or secondary outcomes. Costs were higher in both vitamin K2 arms than in the placebo arm. Oral vitamin K2 supplementation did not improve postural sway or physical function in older people at risk of falls. J Am Geriatr Soc 67:2102-2107, 2019.

Identifiants

pubmed: 31211416
doi: 10.1111/jgs.16024
pmc: PMC6851824
doi:

Substances chimiques

Vitamins 0
Vitamin K 2 11032-49-8

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

2102-2107

Subventions

Organisme : Chief Scientist Office
ID : HERU1
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals, Inc. on behalf of The American Geriatrics Society.

Références

Appl Health Econ Health Policy. 2011 Sep 1;9(5):317-29
pubmed: 21875162
Pharmacol Ther. 2018 Aug;188:97-117
pubmed: 29514053
Nutrients. 2018 Jun 29;10(7):null
pubmed: 29966260
J Gerontol. 1994 Mar;49(2):M72-84
pubmed: 8126355
J Am Geriatr Soc. 1991 Feb;39(2):142-8
pubmed: 1991946
Annu Rev Nutr. 2018 Aug 21;38:127-151
pubmed: 29856932
J Nutr Health Aging. 2016 Mar;20(3):325-33
pubmed: 26892582
Curr Nutr Rep. 2016 Jun;5(2):90-98
pubmed: 27648390
Thromb Haemost. 2010 Oct;104(4):811-22
pubmed: 20694284
J Gerontol A Biol Sci Med Sci. 2008 Feb;63(2):171-8
pubmed: 18314453
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007146
pubmed: 22972103
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Maturitas. 2010 Oct;67(2):121-8
pubmed: 20850029
J Am Geriatr Soc. 2005 Sep;53(9):1618-22
pubmed: 16137297
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Age Ageing. 2010 Nov;39(6):710-6
pubmed: 20833862
Can J Public Health. 1992 Jul-Aug;83 Suppl 2:S7-11
pubmed: 1468055
Thromb Haemost. 2015 May;113(5):1135-44
pubmed: 25694037
Physiotherapy. 2018 Mar;104(1):72-79
pubmed: 28801033
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):399-408
pubmed: 25538207
Nutrients. 2017 Dec 08;9(12):null
pubmed: 29292751
Heart. 2019 Jun;105(12):938-945
pubmed: 30514729
Nutrition. 2016 Jul-Aug;32(7-8):732-9
pubmed: 27133809
Atherosclerosis. 2015 May;240(1):10-6
pubmed: 25744701
Br J Nutr. 2006 Dec;96(6):1105-15
pubmed: 17181886
BMJ. 2008 Jan 19;336(7636):130-3
pubmed: 18089892
Gerontology. 2006;52(1):1-16
pubmed: 16439819

Auteurs

Miles D Witham (MD)

AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals Trust, Newcastle upon Tyne, United Kingdom.
School of Medicine, University of Dundee, Dundee, United Kingdom.

Rosemary J G Price (RJG)

Tayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.

Margaret M Band (MM)

Tayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.

Michael S Hannah (MS)

Tayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.

Roberta L Fulton (RL)

School of Nursing, Abertay University, Dundee, United Kingdom.

Clare L Clarke (CL)

Tayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.

Peter T Donnan (PT)

Tayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom.

Paul McNamee (P)

Health Economics Research Unit, University of Aberdeen, Aberdeen, United Kingdom.

Vera Cvoro (V)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK and NHS Fife, Kirkcaldy, United Kingdom.

Roy L Soiza (RL)

Ageing Clinical and Experimental Research, School of Medicine & Dentistry, University of Aberdeen, Aberdeen, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH